| Cat. No. |
Product Name |
Effect
|
Purity |
Rare Diseases
|
| HY-179528 |
DIM-3,5-Cl2 |
|
99.18% |
Unkown |
| HY-156277 |
SP4f |
Activator |
99.77% |
Unkown |
| HY-156276 |
SP4e |
Activator |
99.72% |
Unkown |
| HY-482945 |
(SP-4-1)-[[4,4′,4′′,4′′′-(21H,23H-Porphine-5,10,15,20-tetrayl-κN21,κN22,κN23,κN24)tetrakis[benzenesulfonato]](6-)]cobaltate(3-) |
|
/ |
Unkown |
| HY-RS13607 |
SP4 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-W075610 |
Nickelate(4-), [[4,4',4'',4'''-(21H,23H-porphine-5,10,15,20-tetrayl)tetrakis[benzoato]](6-)-N21,N22,N23,N24]-, tetrahydrogen, (SP-4-1)- |
|
/ |
Unkown |
| HY-W456409 |
(SP-4-1)-[5,10,15,20-Tetra-4-pyridinyl-21H,23H-porphinato(2-)-κN21,κN22,κN23,κN24]nickel |
|
/ |
Unkown |
| HY-W456534 |
Cuprate(4-), [[4,4′,4′′,4′′′-(21H,23H-porphine-5,10,15,20-tetrayl-κN21,κN22,κN23,κN24)tetrakis[benzoato]](6-)]-, (SP-4-1)- |
|
/ |
Unkown |
| HY-W456551 |
Copper, [2,7,12,17-tetrakis(1,1-dimethylethyl)-21H,23H-porphyrazinato(2-)-κN21,κN22,κN23,κN24]-, (SP-4-1)- |
|
/ |
Unkown |
| HY-W456552 |
(SP-4-1)-[5,10,15,20-Tetrakis(4-ethynylphenyl)-21H,23H-porphinato(2-)-κN21,κN22,κN23,κN24]zinc |
|
/ |
Unkown |
| HY-W456554 |
Zincate(4-), [[4,4′,4′′,4′′′-(21H,23H-porphine-5,10,15,20-tetrayl-κN21,κN22,κN23,κN24)tetrakis[benzenesulfonato]](6-)]-, hydrogen (1:4), (SP-4-1)- |
|
/ |
Unkown |
| HY-W456556 |
(SP-4-1)-[5,10,15,20-Tetraphenyl-21H,23H-porphinato(2-)-κN21,κN22,κN23,κN24]tin |
|
/ |
Unkown |
| HY-W456557 |
(SP-4-1)-[[4,4′,4′′,4′′′-(21H,23H-Porphine-5,10,15,20-tetrayl-κN21,κN22,κN23,κN24)tetrakis[benzoato]](6-)]manganate(3-) |
|
/ |
Unkown |
| HY-W456558 |
(SP-4-1)-[5,10,15,20-Tetrakis(4-methylphenyl)-21H,23H-porphinato(2-)-κN21,κN22,κN23,κN24]manganese |
|
/ |
Unkown |
| HY-W456560 |
(SP-4-1)-[5,10,15,20-Tetrakis(4-methoxyphenyl)-21H,23H-porphinato(2-)-κN21,κN22,κN23,κN24]manganese |
|
/ |
Unkown |
| HY-W543252 |
(SP-4-1)-[[4,4',4'',4'''-(21H,23H-Porphine-5,10,15,20-tetrayl-κN21,κN22,κN23,κN24)tetrakis[benzoato]](6-)]cobaltate(4-) |
|
/ |
Unkown |
| HY-W543724 |
(SP-4-1)-[5,10,15,20-Tetrakis(4-bromophenyl)-21H,23H-porphinato(2-)-κN21,κN22,κN23,κN24]cobalt |
|
/ |
Unkown |
| HY-W855971 |
(SP-4-1)-[29H,31H-phthalocyanine-2,9,16,23-tetracarboxylato(6-)-N29,N30,N31,N32]Nickelate(4-) |
|
/ |
Unkown |
| HY-W855972 |
(SP-4-1)-[29H,31H-Phthalocyanine-2,9,16,23-tetracarboxylato(6-)-κN29,κN30,κN31,κN32]cobaltate(4-) |
|
/ |
Unkown |
| HY-W855973 |
(SP-4-1)-[5,10,15,20-Tetrakis(4-bromophenyl)-21H,23H-porphinato(2-)-κN21,κN22,κN23,κN24]copper |
|
/ |
Unkown |
| HY-W855974 |
(SP-4-1)-[5,10,15,20-Tetrakis(4-bromophenyl)-21H,23H-porphinato(2-)-κN21,κN22,κN23,κN24]nickel |
|
/ |
Unkown |
| HY-RS18331 |
Sp4 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS24810 |
Sp4 Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |